Archive for the 'Cardiovasculers' Category

Further Evidence of CV Harm With Rosiglitazone

More evidence supporting the idea that rosiglitazone (Avandia, GlaxoSmithKline) does increase the risk of cardiovascular events has come from a new population-based study. Read More This Post...


Popularity: 37% [?]

October 21st, 2008 | Posted in Cardiovasculers | 1 Comment

Impaired Chronotropic Response May Evaluate Cardiac Risk in Diabetic Patients

Impaired chronotropic response (CR) after exercise treadmill testing (ETT) is an effective, noninvasive tool to evaluate cardiac risk in patients with diabetes, according to the results of a study reported in the August issue of Diabetes Care. Read More This Post...


Popularity: 80% [?]

August 26th, 2008 | Posted in Cardiovasculers, Diabetes Mellitus | 1 Comment